General Information


DRACP ID  DRACP04452

Peptide Name  

Sequence  WRNWRNWRNWRNWRN

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C105H142N40O21

Absent amino acids  ACDEFGHIKLMPQSTVY

Common amino acids  NRW

Mass  255041

Pl  13.1

Basic residues  5

Acidic residues  0

Hydrophobic residues  5

Net charge  5

Boman Index  -9615

Hydrophobicity  -296.67

Aliphatic Index  0

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  27500

Absorbance 280nm  1964.29

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36115654

Title  The design of cell-selective tryptophan and arginine-rich antimicrobial peptides by introducing hydrophilic uncharged residues

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19947

DRACP is developed by Dr.Zheng's team.